Rank | Gene Set | Z-score |
---|---|---|
1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.38107240 |
2 | DNA deamination (GO:0045006) | 5.20530583 |
3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.20406755 |
4 | ATP synthesis coupled proton transport (GO:0015986) | 5.20406755 |
5 | ribosomal small subunit assembly (GO:0000028) | 4.84537488 |
6 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.70140050 |
7 | viral transcription (GO:0019083) | 4.59081450 |
8 | cytidine metabolic process (GO:0046087) | 4.38134874 |
9 | cytidine catabolic process (GO:0006216) | 4.38134874 |
10 | cytidine deamination (GO:0009972) | 4.38134874 |
11 | translational termination (GO:0006415) | 4.30890489 |
12 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.30770926 |
13 | protein neddylation (GO:0045116) | 4.29680660 |
14 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.20594654 |
15 | chaperone-mediated protein transport (GO:0072321) | 4.12328079 |
16 | respiratory electron transport chain (GO:0022904) | 4.11805315 |
17 | protein complex biogenesis (GO:0070271) | 4.06002507 |
18 | electron transport chain (GO:0022900) | 4.05762986 |
19 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.02584522 |
20 | protein targeting to ER (GO:0045047) | 3.97532431 |
21 | cotranslational protein targeting to membrane (GO:0006613) | 3.96313207 |
22 | sequestering of actin monomers (GO:0042989) | 3.90953980 |
23 | translational elongation (GO:0006414) | 3.85152309 |
24 | protein localization to endoplasmic reticulum (GO:0070972) | 3.79787244 |
25 | ribosomal small subunit biogenesis (GO:0042274) | 3.79591614 |
26 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.76677186 |
27 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.74599526 |
28 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.72235878 |
29 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.68471647 |
30 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.68471647 |
31 | NADH dehydrogenase complex assembly (GO:0010257) | 3.68471647 |
32 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.67365174 |
33 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.67365174 |
34 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.60958339 |
35 | viral life cycle (GO:0019058) | 3.60672760 |
36 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.39582768 |
37 | negative regulation of telomere maintenance (GO:0032205) | 3.35854741 |
38 | cellular protein complex disassembly (GO:0043624) | 3.26370458 |
39 | response to interferon-beta (GO:0035456) | 3.19637067 |
40 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.18041291 |
41 | deoxyribonucleotide catabolic process (GO:0009264) | 3.17382875 |
42 | maturation of SSU-rRNA (GO:0030490) | 3.15174337 |
43 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.10212256 |
44 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.09087890 |
45 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.08281355 |
46 | immunoglobulin mediated immune response (GO:0016064) | 3.05366773 |
47 | platelet dense granule organization (GO:0060155) | 3.04663986 |
48 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.00629314 |
49 | proteasome assembly (GO:0043248) | 3.00542099 |
50 | cellular response to interferon-beta (GO:0035458) | 2.98870206 |
51 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.97794824 |
52 | cytochrome complex assembly (GO:0017004) | 2.97694790 |
53 | translational initiation (GO:0006413) | 2.97053195 |
54 | deoxyribose phosphate catabolic process (GO:0046386) | 2.96324222 |
55 | ATP biosynthetic process (GO:0006754) | 2.93306415 |
56 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.92852760 |
57 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.91213542 |
58 | iron-sulfur cluster assembly (GO:0016226) | 2.90747343 |
59 | metallo-sulfur cluster assembly (GO:0031163) | 2.90747343 |
60 | hydrogen ion transmembrane transport (GO:1902600) | 2.88163820 |
61 | translation (GO:0006412) | 2.86214327 |
62 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.84881690 |
63 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.84881690 |
64 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.84227495 |
65 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.84227495 |
66 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.84227495 |
67 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.84114462 |
68 | negative regulation of B cell apoptotic process (GO:0002903) | 2.80141441 |
69 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.80063728 |
70 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.79938171 |
71 | T cell migration (GO:0072678) | 2.79651129 |
72 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.79420789 |
73 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.78686024 |
74 | protein complex disassembly (GO:0043241) | 2.77563102 |
75 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.76895878 |
76 | negative regulation of ligase activity (GO:0051352) | 2.76243077 |
77 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.76243077 |
78 | inner mitochondrial membrane organization (GO:0007007) | 2.74701803 |
79 | viral protein processing (GO:0019082) | 2.73021575 |
80 | termination of RNA polymerase III transcription (GO:0006386) | 2.72556376 |
81 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.72556376 |
82 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.72304251 |
83 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.68775338 |
84 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.68485510 |
85 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.68282085 |
86 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.67960888 |
87 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.66882168 |
88 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.66882168 |
89 | macromolecular complex disassembly (GO:0032984) | 2.65490050 |
90 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.64609963 |
91 | establishment of protein localization to mitochondrion (GO:0072655) | 2.64310534 |
92 | NIK/NF-kappaB signaling (GO:0038061) | 2.63328407 |
93 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.63036029 |
94 | proton transport (GO:0015992) | 2.63006838 |
95 | respiratory chain complex IV assembly (GO:0008535) | 2.62636027 |
96 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.62285932 |
97 | positive regulation of defense response to virus by host (GO:0002230) | 2.62017545 |
98 | protein targeting to mitochondrion (GO:0006626) | 2.61791785 |
99 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.61225596 |
100 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.59952487 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.93356458 |
2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.76608223 |
3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.55008774 |
4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.42639212 |
5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.40055223 |
6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.38595399 |
7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.30744688 |
8 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.29888062 |
9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.10028817 |
10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.92595990 |
11 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.83858345 |
12 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.71737947 |
13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.69393478 |
14 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.42987168 |
15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.39138548 |
16 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.34735536 |
17 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.29870934 |
18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.18818875 |
19 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.16369240 |
20 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.16072660 |
21 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.12458721 |
22 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.11456051 |
23 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.06141772 |
24 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.04339060 |
25 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.01391800 |
26 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.01359836 |
27 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.93680757 |
28 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.88921640 |
29 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.88182251 |
30 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74870138 |
31 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.71020390 |
32 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.69070519 |
33 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.68960111 |
34 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.67172435 |
35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65528989 |
36 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.60321551 |
37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.58654979 |
38 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.57475829 |
39 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.54562399 |
40 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.54435144 |
41 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54017600 |
42 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.52492539 |
43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.49283194 |
44 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.49148626 |
45 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.45687509 |
46 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.41048153 |
47 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.39617777 |
48 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.39338572 |
49 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.38001594 |
50 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.37782057 |
51 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.33504273 |
52 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.33246939 |
53 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.31470456 |
54 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.31002153 |
55 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.30389122 |
56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29795217 |
57 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.29745262 |
58 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.28943000 |
59 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.28118885 |
60 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.25322999 |
61 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.25077600 |
62 | MAF_26560356_Chip-Seq_TH2_Human | 1.21926226 |
63 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.20301052 |
64 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17427368 |
65 | * MYB_26560356_Chip-Seq_TH2_Human | 1.16961465 |
66 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.15092834 |
67 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.14734979 |
68 | UTX_26944678_Chip-Seq_JUKART_Human | 1.14456251 |
69 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.14096979 |
70 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.11852417 |
71 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09718396 |
72 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.08814205 |
73 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.07224445 |
74 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.06539040 |
75 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.05830397 |
76 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.05802423 |
77 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04963861 |
78 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.04607213 |
79 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.03234435 |
80 | P300_27268052_Chip-Seq_Bcells_Human | 1.01295031 |
81 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.99981579 |
82 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.99562693 |
83 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99433571 |
84 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.99121003 |
85 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.98892347 |
86 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.97761553 |
87 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.97000670 |
88 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96697433 |
89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95374397 |
90 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.93435974 |
91 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.93259300 |
92 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92600328 |
93 | * MAF_26560356_Chip-Seq_TH1_Human | 0.92318845 |
94 | GATA3_26560356_Chip-Seq_TH2_Human | 0.92263275 |
95 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.92168778 |
96 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.92084045 |
97 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.91910746 |
98 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.90975754 |
99 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.90959536 |
100 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.90954851 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005671_abnormal_response_to | 3.93451114 |
2 | MP0001835_abnormal_antigen_presentation | 2.68687881 |
3 | MP0009379_abnormal_foot_pigmentation | 2.65325050 |
4 | MP0002148_abnormal_hypersensitivity_rea | 2.57517977 |
5 | MP0009785_altered_susceptibility_to | 2.53809868 |
6 | MP0002653_abnormal_ependyma_morphology | 2.51317049 |
7 | MP0001800_abnormal_humoral_immune | 2.32128646 |
8 | MP0005387_immune_system_phenotype | 2.27607382 |
9 | MP0001790_abnormal_immune_system | 2.27607382 |
10 | MP0005084_abnormal_gallbladder_morpholo | 2.26073485 |
11 | MP0005000_abnormal_immune_tolerance | 2.22770683 |
12 | MP0002723_abnormal_immune_serum | 2.11448257 |
13 | MP0005025_abnormal_response_to | 2.09953311 |
14 | MP0006292_abnormal_olfactory_placode | 2.07496754 |
15 | MP0000685_abnormal_immune_system | 1.99888204 |
16 | MP0002420_abnormal_adaptive_immunity | 1.97550774 |
17 | MP0001819_abnormal_immune_cell | 1.94256948 |
18 | MP0009333_abnormal_splenocyte_physiolog | 1.93167199 |
19 | MP0002138_abnormal_hepatobiliary_system | 1.88966787 |
20 | MP0006082_CNS_inflammation | 1.88891916 |
21 | MP0003436_decreased_susceptibility_to | 1.88853588 |
22 | MP0002452_abnormal_antigen_presenting | 1.87813706 |
23 | MP0008789_abnormal_olfactory_epithelium | 1.87222263 |
24 | MP0002277_abnormal_respiratory_mucosa | 1.84970690 |
25 | MP0003806_abnormal_nucleotide_metabolis | 1.80831326 |
26 | MP0003763_abnormal_thymus_physiology | 1.80018671 |
27 | MP0000372_irregular_coat_pigmentation | 1.73379101 |
28 | MP0004142_abnormal_muscle_tone | 1.72805957 |
29 | MP0002163_abnormal_gland_morphology | 1.62097267 |
30 | MP0003724_increased_susceptibility_to | 1.59875254 |
31 | MP0003011_delayed_dark_adaptation | 1.59450035 |
32 | MP0005075_abnormal_melanosome_morpholog | 1.57207015 |
33 | MP0002398_abnormal_bone_marrow | 1.57134896 |
34 | MP0000716_abnormal_immune_system | 1.54995272 |
35 | MP0002419_abnormal_innate_immunity | 1.54624807 |
36 | MP0005394_taste/olfaction_phenotype | 1.54437071 |
37 | MP0005499_abnormal_olfactory_system | 1.54437071 |
38 | MP0008995_early_reproductive_senescence | 1.53021552 |
39 | MP0001905_abnormal_dopamine_level | 1.52101729 |
40 | MP0005645_abnormal_hypothalamus_physiol | 1.49503862 |
41 | MP0008877_abnormal_DNA_methylation | 1.49386811 |
42 | MP0002405_respiratory_system_inflammati | 1.45980989 |
43 | MP0000689_abnormal_spleen_morphology | 1.42194936 |
44 | MP0004147_increased_porphyrin_level | 1.39458822 |
45 | MP0003186_abnormal_redox_activity | 1.37346767 |
46 | MP0006072_abnormal_retinal_apoptosis | 1.37049872 |
47 | MP0008058_abnormal_DNA_repair | 1.36547830 |
48 | MP0003786_premature_aging | 1.34540476 |
49 | MP0006036_abnormal_mitochondrial_physio | 1.34285499 |
50 | MP0001845_abnormal_inflammatory_respons | 1.31749660 |
51 | MP0001529_abnormal_vocalization | 1.30458522 |
52 | MP0009764_decreased_sensitivity_to | 1.28964152 |
53 | MP0002722_abnormal_immune_system | 1.28354601 |
54 | MP0002429_abnormal_blood_cell | 1.27441401 |
55 | MP0002638_abnormal_pupillary_reflex | 1.26175054 |
56 | MP0001873_stomach_inflammation | 1.24187788 |
57 | MP0005464_abnormal_platelet_physiology | 1.20386751 |
58 | MP0002102_abnormal_ear_morphology | 1.18740064 |
59 | MP0003122_maternal_imprinting | 1.18071002 |
60 | MP0001853_heart_inflammation | 1.16189021 |
61 | MP0009278_abnormal_bone_marrow | 1.16131940 |
62 | MP0003866_abnormal_defecation | 1.10701042 |
63 | MP0002736_abnormal_nociception_after | 1.07944799 |
64 | MP0002822_catalepsy | 1.07442275 |
65 | MP0008469_abnormal_protein_level | 1.06064515 |
66 | MP0003787_abnormal_imprinting | 1.05645614 |
67 | MP0001986_abnormal_taste_sensitivity | 1.05172244 |
68 | MP0010155_abnormal_intestine_physiology | 1.05097191 |
69 | MP0004742_abnormal_vestibular_system | 1.04546832 |
70 | MP0001984_abnormal_olfaction | 1.01845610 |
71 | MP0000703_abnormal_thymus_morphology | 1.01501641 |
72 | MP0002132_abnormal_respiratory_system | 0.99163868 |
73 | MP0003646_muscle_fatigue | 0.96492981 |
74 | MP0006276_abnormal_autonomic_nervous | 0.95481778 |
75 | MP0001968_abnormal_touch/_nociception | 0.94823258 |
76 | MP0003303_peritoneal_inflammation | 0.94400984 |
77 | MP0006035_abnormal_mitochondrial_morpho | 0.92393230 |
78 | MP0001919_abnormal_reproductive_system | 0.92215870 |
79 | MP0001533_abnormal_skeleton_physiology | 0.91914940 |
80 | MP0004510_myositis | 0.90659850 |
81 | MP0003136_yellow_coat_color | 0.90370156 |
82 | MP0005379_endocrine/exocrine_gland_phen | 0.90305197 |
83 | MP0004885_abnormal_endolymph | 0.89045759 |
84 | MP0000343_altered_response_to | 0.87662313 |
85 | MP0001545_abnormal_hematopoietic_system | 0.85877104 |
86 | MP0005397_hematopoietic_system_phenotyp | 0.85877104 |
87 | MP0001542_abnormal_bone_strength | 0.85852866 |
88 | MP0001663_abnormal_digestive_system | 0.85579120 |
89 | MP0002095_abnormal_skin_pigmentation | 0.84914938 |
90 | MP0008872_abnormal_physiological_respon | 0.84905161 |
91 | MP0003880_abnormal_central_pattern | 0.84592673 |
92 | MP0003121_genomic_imprinting | 0.82807382 |
93 | MP0002837_dystrophic_cardiac_calcinosis | 0.82798945 |
94 | MP0000465_gastrointestinal_hemorrhage | 0.82671361 |
95 | MP0009765_abnormal_xenobiotic_induced | 0.81455137 |
96 | MP0002933_joint_inflammation | 0.80950514 |
97 | MP0009745_abnormal_behavioral_response | 0.78989296 |
98 | MP0001970_abnormal_pain_threshold | 0.78125974 |
99 | MP0001764_abnormal_homeostasis | 0.75096117 |
100 | MP0001485_abnormal_pinna_reflex | 0.72431732 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Acute necrotizing encephalopathy (HP:0006965) | 5.10894351 |
2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.75360147 |
3 | Mitochondrial inheritance (HP:0001427) | 4.71874376 |
4 | Acute encephalopathy (HP:0006846) | 4.29126986 |
5 | Progressive macrocephaly (HP:0004481) | 4.14120393 |
6 | Hepatocellular necrosis (HP:0001404) | 4.08186678 |
7 | Increased CSF lactate (HP:0002490) | 4.05783509 |
8 | Hepatic necrosis (HP:0002605) | 3.68493737 |
9 | Reticulocytopenia (HP:0001896) | 3.58634696 |
10 | Increased hepatocellular lipid droplets (HP:0006565) | 3.55814220 |
11 | Abnormal number of erythroid precursors (HP:0012131) | 3.44586090 |
12 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.43726727 |
13 | 3-Methylglutaconic aciduria (HP:0003535) | 3.36904184 |
14 | Lipid accumulation in hepatocytes (HP:0006561) | 3.33350621 |
15 | Increased intramyocellular lipid droplets (HP:0012240) | 3.32273104 |
16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.23852814 |
17 | Renal Fanconi syndrome (HP:0001994) | 3.21754507 |
18 | Cerebral edema (HP:0002181) | 3.11672913 |
19 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.98558748 |
20 | Increased IgM level (HP:0003496) | 2.92076600 |
21 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.91714671 |
22 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.91714671 |
23 | Increased muscle lipid content (HP:0009058) | 2.91255505 |
24 | IgG deficiency (HP:0004315) | 2.89593030 |
25 | Stomatitis (HP:0010280) | 2.78060530 |
26 | Optic disc pallor (HP:0000543) | 2.75545813 |
27 | Exertional dyspnea (HP:0002875) | 2.66671409 |
28 | Aplastic anemia (HP:0001915) | 2.66490489 |
29 | Lactic acidosis (HP:0003128) | 2.66133567 |
30 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.59901812 |
31 | Exercise intolerance (HP:0003546) | 2.54931151 |
32 | Increased serum lactate (HP:0002151) | 2.50913258 |
33 | Respiratory difficulties (HP:0002880) | 2.48197167 |
34 | IgM deficiency (HP:0002850) | 2.47748854 |
35 | Neutropenia (HP:0001875) | 2.46441998 |
36 | Abnormality of B cell number (HP:0010975) | 2.44530526 |
37 | Obstructive lung disease (HP:0006536) | 2.44276128 |
38 | Chronic obstructive pulmonary disease (HP:0006510) | 2.44276128 |
39 | Panhypogammaglobulinemia (HP:0003139) | 2.36653930 |
40 | Agammaglobulinemia (HP:0004432) | 2.36278851 |
41 | Respiratory failure (HP:0002878) | 2.32771694 |
42 | Abnormality of the prostate (HP:0008775) | 2.27739227 |
43 | Methylmalonic aciduria (HP:0012120) | 2.27527605 |
44 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.27033265 |
45 | Pancytopenia (HP:0001876) | 2.26591950 |
46 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.26525766 |
47 | Dicarboxylic aciduria (HP:0003215) | 2.26525766 |
48 | Type I transferrin isoform profile (HP:0003642) | 2.23249214 |
49 | Abnormality of T cells (HP:0002843) | 2.20318531 |
50 | Macrocytic anemia (HP:0001972) | 2.19377074 |
51 | B lymphocytopenia (HP:0010976) | 2.17853918 |
52 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.14798063 |
53 | Meningitis (HP:0001287) | 2.14188287 |
54 | Severe combined immunodeficiency (HP:0004430) | 2.13199601 |
55 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.11927579 |
56 | Pallor (HP:0000980) | 2.10616191 |
57 | Polyphagia (HP:0002591) | 2.09882957 |
58 | Congenital stationary night blindness (HP:0007642) | 2.08299551 |
59 | Lethargy (HP:0001254) | 2.07870300 |
60 | Abnormality of midbrain morphology (HP:0002418) | 2.07384021 |
61 | Molar tooth sign on MRI (HP:0002419) | 2.07384021 |
62 | Abnormal protein glycosylation (HP:0012346) | 2.06667823 |
63 | Abnormal glycosylation (HP:0012345) | 2.06667823 |
64 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.06667823 |
65 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.06667823 |
66 | Muscle fiber atrophy (HP:0100295) | 2.06355542 |
67 | Emotional lability (HP:0000712) | 2.02477009 |
68 | Petechiae (HP:0000967) | 2.02467975 |
69 | Leukodystrophy (HP:0002415) | 1.99473743 |
70 | Abnormality of T cell number (HP:0011839) | 1.99080304 |
71 | Medial flaring of the eyebrow (HP:0010747) | 1.97656738 |
72 | Pancreatic cysts (HP:0001737) | 1.97607539 |
73 | Lymphopenia (HP:0001888) | 1.97012116 |
74 | Type 2 muscle fiber atrophy (HP:0003554) | 1.95228636 |
75 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.94382974 |
76 | Encephalitis (HP:0002383) | 1.94062838 |
77 | T lymphocytopenia (HP:0005403) | 1.92890409 |
78 | Cerebral palsy (HP:0100021) | 1.92610523 |
79 | Colon cancer (HP:0003003) | 1.92062472 |
80 | Abnormality of renal resorption (HP:0011038) | 1.90781975 |
81 | Pancreatic fibrosis (HP:0100732) | 1.90659107 |
82 | Methylmalonic acidemia (HP:0002912) | 1.89948737 |
83 | Mediastinal lymphadenopathy (HP:0100721) | 1.88592892 |
84 | Granulocytopenia (HP:0001913) | 1.85302215 |
85 | Absent thumb (HP:0009777) | 1.84716099 |
86 | True hermaphroditism (HP:0010459) | 1.84510566 |
87 | Septo-optic dysplasia (HP:0100842) | 1.82871453 |
88 | Severe visual impairment (HP:0001141) | 1.82865865 |
89 | Generalized aminoaciduria (HP:0002909) | 1.81845627 |
90 | Abnormality of eosinophils (HP:0001879) | 1.80015849 |
91 | Constricted visual fields (HP:0001133) | 1.79656998 |
92 | Abnormality of the labia minora (HP:0012880) | 1.79431366 |
93 | Combined immunodeficiency (HP:0005387) | 1.79070957 |
94 | Eosinophilia (HP:0001880) | 1.78723005 |
95 | Progressive microcephaly (HP:0000253) | 1.78181671 |
96 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.77661531 |
97 | Recurrent fungal infections (HP:0002841) | 1.76170525 |
98 | Vasculitis (HP:0002633) | 1.75939679 |
99 | Pulmonary fibrosis (HP:0002206) | 1.75078886 |
100 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.72632455 |
Rank | Gene Set | Z-score |
---|---|---|
1 | VRK2 | 4.36505901 |
2 | TXK | 4.00757923 |
3 | BCKDK | 3.62740286 |
4 | TESK2 | 3.32607396 |
5 | MAP4K1 | 3.28324457 |
6 | KDR | 2.73343953 |
7 | TAOK3 | 2.72338633 |
8 | STK16 | 2.49224398 |
9 | MAP4K2 | 2.34995408 |
10 | CDK19 | 2.29306026 |
11 | NME2 | 2.23713305 |
12 | VRK1 | 2.13395359 |
13 | TESK1 | 1.82941203 |
14 | NUAK1 | 1.71958216 |
15 | FES | 1.70745184 |
16 | MAP3K11 | 1.66235607 |
17 | TLK1 | 1.63989044 |
18 | ADRBK2 | 1.60044703 |
19 | LIMK1 | 1.59387607 |
20 | KIT | 1.58161592 |
21 | DYRK2 | 1.56214834 |
22 | ARAF | 1.53868129 |
23 | ZAK | 1.49235389 |
24 | SYK | 1.37228482 |
25 | GRK7 | 1.36757294 |
26 | IKBKB | 1.35879065 |
27 | BUB1 | 1.33063442 |
28 | PIM2 | 1.32582413 |
29 | RIPK4 | 1.16701044 |
30 | IKBKE | 1.14661944 |
31 | TBK1 | 1.03526632 |
32 | MAP3K12 | 1.01540162 |
33 | IRAK4 | 0.99493533 |
34 | MAP2K7 | 0.96948204 |
35 | SIK2 | 0.96118612 |
36 | BTK | 0.92548018 |
37 | LYN | 0.92317558 |
38 | CSNK1G3 | 0.91045060 |
39 | PRKCQ | 0.89870469 |
40 | ITK | 0.88691231 |
41 | SRPK1 | 0.86978139 |
42 | BRAF | 0.86881612 |
43 | MATK | 0.85324737 |
44 | BMPR1B | 0.83875309 |
45 | WNK3 | 0.83647896 |
46 | NME1 | 0.82544633 |
47 | RPS6KA5 | 0.80905177 |
48 | GRK6 | 0.80794047 |
49 | MARK3 | 0.79096558 |
50 | TRIM28 | 0.78046621 |
51 | PINK1 | 0.77859038 |
52 | LRRK2 | 0.74192763 |
53 | TAF1 | 0.73898954 |
54 | AURKA | 0.73107559 |
55 | CSNK1G2 | 0.72204837 |
56 | TNK2 | 0.71883269 |
57 | CCNB1 | 0.71311677 |
58 | MOS | 0.71221555 |
59 | MAPK13 | 0.71032139 |
60 | CSF1R | 0.70701297 |
61 | ABL2 | 0.69346342 |
62 | TYK2 | 0.68951812 |
63 | PASK | 0.68344070 |
64 | LCK | 0.67177296 |
65 | CSNK1G1 | 0.66817319 |
66 | GRK1 | 0.65731441 |
67 | SIK3 | 0.65329990 |
68 | TEC | 0.64873768 |
69 | CSK | 0.64848785 |
70 | DAPK1 | 0.63619444 |
71 | DAPK3 | 0.63407476 |
72 | JAK3 | 0.55787998 |
73 | ZAP70 | 0.54454276 |
74 | PIM1 | 0.52940185 |
75 | PRKCG | 0.51327617 |
76 | PAK1 | 0.49016548 |
77 | RPS6KA4 | 0.47791835 |
78 | GRK5 | 0.47280878 |
79 | CDC7 | 0.46933909 |
80 | CSNK1A1L | 0.46238341 |
81 | MST4 | 0.45314683 |
82 | PKN1 | 0.44437802 |
83 | CSNK2A1 | 0.42726699 |
84 | PRKCD | 0.41105915 |
85 | BLK | 0.40328035 |
86 | INSRR | 0.39990494 |
87 | ATR | 0.39961840 |
88 | DYRK1B | 0.38692265 |
89 | MAPK15 | 0.38663961 |
90 | CDK8 | 0.38634297 |
91 | CDK14 | 0.38491509 |
92 | CSNK2A2 | 0.38449304 |
93 | ILK | 0.37905960 |
94 | DYRK3 | 0.37903282 |
95 | MAP2K2 | 0.37402261 |
96 | TAOK2 | 0.36914444 |
97 | EPHB2 | 0.35312821 |
98 | ADRBK1 | 0.35046180 |
99 | CDK11A | 0.31347239 |
100 | HCK | 0.31289064 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.40756813 |
2 | Ribosome_Homo sapiens_hsa03010 | 4.18099597 |
3 | Proteasome_Homo sapiens_hsa03050 | 3.85443675 |
4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.82983983 |
5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.96373621 |
6 | Allograft rejection_Homo sapiens_hsa05330 | 2.70184800 |
7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.59620852 |
8 | Asthma_Homo sapiens_hsa05310 | 2.58066009 |
9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.57777334 |
10 | Huntingtons disease_Homo sapiens_hsa05016 | 2.47096193 |
11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.45899607 |
12 | Alzheimers disease_Homo sapiens_hsa05010 | 2.41119397 |
13 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.30391467 |
14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.18349497 |
15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.15492912 |
16 | RNA polymerase_Homo sapiens_hsa03020 | 2.14585442 |
17 | Protein export_Homo sapiens_hsa03060 | 2.05811192 |
18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.92731992 |
19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.61244667 |
20 | Mismatch repair_Homo sapiens_hsa03430 | 1.55554579 |
21 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.54088151 |
22 | DNA replication_Homo sapiens_hsa03030 | 1.50458749 |
23 | Homologous recombination_Homo sapiens_hsa03440 | 1.50215507 |
24 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.48377330 |
25 | Base excision repair_Homo sapiens_hsa03410 | 1.47270032 |
26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.44439927 |
27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.34033407 |
28 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.29524866 |
29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.19151328 |
30 | Sulfur relay system_Homo sapiens_hsa04122 | 1.17069206 |
31 | Spliceosome_Homo sapiens_hsa03040 | 1.15726227 |
32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.98737592 |
33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.96860930 |
34 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.95536304 |
35 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.93125881 |
36 | RNA degradation_Homo sapiens_hsa03018 | 0.92506605 |
37 | Leishmaniasis_Homo sapiens_hsa05140 | 0.92172640 |
38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.91141960 |
39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.88562734 |
40 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.87486006 |
41 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.87272386 |
42 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.84941604 |
43 | Phototransduction_Homo sapiens_hsa04744 | 0.83737893 |
44 | Basal transcription factors_Homo sapiens_hsa03022 | 0.82515267 |
45 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.80367818 |
46 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.79169243 |
47 | Purine metabolism_Homo sapiens_hsa00230 | 0.77843257 |
48 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76111595 |
49 | Peroxisome_Homo sapiens_hsa04146 | 0.73857013 |
50 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.73494687 |
51 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.72937970 |
52 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72909853 |
53 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.71166477 |
54 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.70072015 |
55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.68535234 |
56 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.67519871 |
57 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.66360031 |
58 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.62330857 |
59 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.61052605 |
60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.58807905 |
61 | Salmonella infection_Homo sapiens_hsa05132 | 0.57588006 |
62 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.55967156 |
63 | Shigellosis_Homo sapiens_hsa05131 | 0.53371124 |
64 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.52740728 |
65 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.52510316 |
66 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.50718018 |
67 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.50533093 |
68 | Measles_Homo sapiens_hsa05162 | 0.50294023 |
69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49456232 |
70 | Phagosome_Homo sapiens_hsa04145 | 0.49378700 |
71 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.48331848 |
72 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.47752688 |
73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.46932498 |
74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.46001803 |
75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45247931 |
76 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.43619259 |
77 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43322143 |
78 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.41563960 |
79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40683569 |
80 | Tuberculosis_Homo sapiens_hsa05152 | 0.39713971 |
81 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.39063312 |
82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.36181632 |
83 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.35380786 |
84 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.32485207 |
85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.32437379 |
86 | Legionellosis_Homo sapiens_hsa05134 | 0.31987846 |
87 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.31958518 |
88 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.27027657 |
89 | Pertussis_Homo sapiens_hsa05133 | 0.26677253 |
90 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.26388690 |
91 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.24711091 |
92 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.24281653 |
93 | Influenza A_Homo sapiens_hsa05164 | 0.21604893 |
94 | Malaria_Homo sapiens_hsa05144 | 0.21392872 |
95 | HTLV-I infection_Homo sapiens_hsa05166 | 0.20968856 |
96 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.20822539 |
97 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.20619461 |
98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.19478862 |
99 | Alcoholism_Homo sapiens_hsa05034 | 0.18561822 |
100 | RNA transport_Homo sapiens_hsa03013 | 0.18445898 |